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Assaying activation of signal transduction is laborious and does
not allow the study of large numbers of samples, essential for
high-throughput drug screens or for large groups of patients.
Using phosphospecific antibodies, we have developed ELISA
techniques enabling non-radioactive semi-quantitative assess-
ment of the activation state of p42}p44 mitogen-activated protein
kinase (MAPK), p38 MAPK, protein kinase B and the tran-
scription factor cAMP-response-element-binding protein
(CREB) in 96-well plates. This assay has been termed PACE
(phosphospecific antibody cell-based ELISA) and was used
successfully for both adherent and suspension cells. Various
INTRODUCTION
Cells must continuously adapt to external stimuli. The molecular
details of most of the underlying signalling pathways have now
been partially clarified and frequently involve the sequential
phosphorylation of the molecules involved. One well-charac-
terized cascade is the signalling pathway initiated by active p21
Ras leading to the sequential activation of Raf, mitogen-activated
protein kinase (MAPK) kinase (MEK) and p42}p44 MAPK
[1–4]. Other signalling cascades, analogous to this pathway, lead
to the phosphorylation and stimulation of p38 MAPK and
stress-activated protein kinase}Jun N-terminal kinase (SAPK}
JNK), which both show significant sequence homology to
p42}p44 MAPK. Aberrant control of these signal-transduction
pathways has been implicated in a variety of pathological
conditions and is therefore an interesting target for both drug
discovery and research into the alterations of signal transduction
in primary material isolated from individual patients.
Unfortunately, current methods for assaying activation of p38
MAPK, p42}p44 MAPK or SAPK}JNK, such as Western
blotting and gel-based kinase assays, are labour-intensive and do
not allow the study of large numbers of samples. The situation
has improved recently with the advent of phosphospecific anti-
bodies, which recognize the phosphorylated forms of proteins
but not their unphosphorylated counterparts. However, analysis
still requires SDS}PAGE followed by Western blotting and this
will typically not allow simultaneous loading of more than 20
samples. Therefore, this technique is still not suited for appli-
cations such as drug discovery or the testing of large numbers of
patients, and alternatives are called for.
The same situation holds true for other signal-transduction
components, such as c-Akt}protein kinase B (PKB) [5,6], which
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stimuli induced dose-dependent enzymic activity of which the
kinetics closely correlated with those measured via classical
methodology. Using PACE we have now characterized for the
first time the concentration-dependent effects of various inflam-
matory prostaglandins on CREB phosphorylation in macro-
phages. PACE is a straightforward and novel technique enabling
the large-scale analysis of signal transduction.
Key words: CREB, granulocyte, high-throughput screening,
macrophage, prostaglandin.
constitutes an important cellular survival signal [7]. Detection of
c-Akt}PKB activity remains dependent on kinase assays or
Western blotting. Similarly, cAMP-dependent transactivation of
cAMP-response-element-containing promoters through protein
kinase A and phosphorylation of cAMP-response-element-bind-
ing protein (CREB) [8,9] remains a difficult target for high-
throughput screening.
We therefore developed an ELISA-based assay to measure the
activation of specific signalling pathways by employing phospho-
specific antibodies, which recognize only the phosphorylated
(activated) state of signalling components. We used these anti-
bodies to determine immunoreactivity of cells grown in 96-well
plates exposed to various stimuli and we have thus created the
phosphospecific antibody cell-based ELISA (PACE). PACE and
similar ELISA-based techniques are non-radioactive semi-quan-
titative assays of signal-transduction pathways that are suited for
the investigation of large numbers of samples and allow high-
throughput screening. We suggest that the assessment of signal
transduction by PACE will become the technique of choice for
rapid analysis.
MATERIALS AND METHODS
Materials and cell culture
N-Formylmethionyl-leucylphenylalanine (fMLP), poly-l-lysine,
o-phenylenediamine dihydrochloride (OPD) and BSA were from
Sigma (St. Louis, MO, U.S.A.). Human serum albumin was
from the Central Laboratory of the Netherlands Red Cross
Blood Transfusion Service (Amsterdam, The Netherlands).
Ficoll-Paque was from Pharmacia (Uppsala, Sweden). The
polyclonal antibody against p44}42 MAPK was from UBI (Lake
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Placid, NY, U.S.A.) and polyclonal anti-phospho-p44}42
MAPK, anti-phospho-p38 MAPK, anti-phospho-c-Akt}PKB
and anti-phospho-CREB antibodies were from New England
Biolabs (Beverly, MA, U.S.A.), as were all in itro kinase-assay
kits. Pig anti-rabbit peroxidase-conjugated antibody and goat
anti-rabbit antibody were from Dako. PD98059 was from Biomol
(Plymouth Meeting, PA, U.S.A.). Murine macrophages clone
4}4 [10] were cultured according to routine procedures. Blood
was obtained from healthy volunteers. Mixed granulocytes were
isolated as described earlier [11].
Cell-based ELISA for adherent cells
Cultured murine macrophages were seeded in 96-well plates
(Maxisorp, Nunc) at 50000 cells}cm#. When appropriate, the
cells were serum-starved for 4 h and stimulated for 10 min. After
stimulation, the cells were fixed with 4% formaldehyde in PBS
for 20 min at room temperature and washed three times
with PBS containing 0.1% Triton X-100 (hereafter referred to as
PBS}Triton). Endogenous peroxidase was quenched with 0.6%
H
#
O
#
in PBS}Triton for 20 min, washed three times in PBS}
Triton, blocked with 10% fetal calf serum in PBS}Triton for 1 h
and incubated overnight with various dilutions of primary
antibody in PBS}Triton containing 5% BSA at 4 °C. Next day,
cells were washed three times with PBS}Triton for 5 min and
incubated with secondary antibody (peroxidase-conjugated goat
anti-rabbit antibody, dilution 1:100) in PBS}Triton with 5%
BSA for 1 h at room temperature and washed three times with
PBS}Triton for 5 min and twice with PBS. Subsequently the cells
were incubated with 50 ll of a solution containing 0.4 mg}ml
OPD, 11.8 mg}ml Na
#
HPO
%
[2H
#
O, 7.3 mg}ml citric acid and
0.015% H
#
O
#
for 15 min at room temperature in the dark. The
reaction was stopped with 25 ll of 1 M H
#
SO
%
, the A
%*!/’&!
was
measured and S.E.M. values were determined (see the error bars
in Figures).
Cell-based ELISA for non-adherent cells
A 96-well plate was coated with 10 lg}ml poly-l-lysine for
30 min at 37 °C. After two washes with sterile PBS, 1.5‹10&
granulocytes were plated into each well and incubated for 30 min
at 37 °C. Granulocytes were stimulated with fMLP and fixed
with 8% formaldehyde in PBS for 20 min at room temperature,
followed by three washes with PBS}Triton. Quenching was
performed with 1% H
#
O
#
and 0.1% sodium azide in PBS}Triton
for 20 min and cells were treated further as described for adherent
cells with the exception of the use of a 1:500 dilution of the
secondary antibody (peroxidase-conjugated pig anti-rabbit) in
PBS}Triton with 5% BSA for 1 h at room temperature.
Crystal violet cell-quantification assay
After the peroxidase reaction, the cells were washed twice with
PBS}Triton and twice with demineralized water. After drying
the wells for 5 min, 100 ll of crystal violet solution [0.04%
crystal violet in 4% (v}v) ethanol] was added for 30 min at room
temperature. Subsequently, the cells were washed at least three
times with demineralized water and 100 ll of 1% SDS solution
was added and incubated on a shaker for 1 h at room tem-
perature. Finally, the absorbance was measured at 595 nm with
an ELISA reader.
In vitro kinase assays
Murine macrophages were grown in either 6-well plates (p42}p44
MAPK assay) or 60-mm dishes (p38 MAPK and PKB assays)
and serum starved for 16 h. After appropiate stimulation cells
were treated according to the manufacturer of the assay kits
(New England Biolabs).
Western blotting
Cell lysate or kinase reaction mix (both 40 ll) was loaded on to
SDS}polyacrylamide gels and blotted on to PVDF membranes.
After blocking and washing, bands were visualized using the
appropriate phosphospecific antibodies (1 :1000), peroxidase-
conjugated goat anti-rabbit antibody (1:2000) and enhanced
chemiluminescence.
RESULTS AND DISCUSSION
Development of a p42/p44 MAPK phosphorylation assay in
96-well plates
Activation of p42}p44 MAPK is accomplished by phosphoryl-
ation of the protein on threonine")$}tyrosine")& and threonine#!#}
tyrosine#!% by MEK [4], and commercial antibodies recognizing
phosphorylated p42}p44 MAPK with little cross-reactivity to
Figure 1 Results of a p42/p44 MAPK PACE
(A) Clone 4/4 macrophage cells were grown in a 96-well plate, stimulated with the indicated
concentrations of PMA (TPA) and subjected to PACE procedures. Results obtained with different
dilutions of the polyclonal anti-phospho-p42/p44 MAPK antibody as primary antibody are
shown. Phosphorylation and activity of MAPK was determined by analysis on Western blot (B)
and an in vitro kinase assay (C). ERK, extracellular-signal-regulated kinase.
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Figure 2 fMLP-mediated p42/p44 MAPK activation in neutrophils measured by PACE
Human neutrophils were isolated from peripheral blood, adhered to poly-L-lysine-coated 96-well plates and stimulated for 2 min with fMLP (D) or PD98059 and fMLP (E ; left-hand panel). The
right-hand panel shows the effects of 10−7 M fMLP for different time periods. After stimulation p42/p44 MAPK PACE was performed. ERK, extracellular-signal-regulated kinase.
the unphosphorylated form of MAPK or other cellular proteins
are available (Figure 1). We analysed how these antibodies
would perform when used for an ELISA-based assay. Therefore,
clone 4}4 macrophages were challenged with different concen-
trations of PMA, a potent activator of MAPK in these cells.
Subsequently, the cells were fixed, blocked, washed (see the
Materials and methods section) and incubated with different
concentrations of anti-phospho-p42}p44 MAPK antibody fol-
lowed by further routine ELISA procedures, finally culminating
in oxidation of OPD by a peroxidase reaction and determination
of absorbance at 490}650 nm. We have termed this procedure
PACE. As evident from Figure 1, in unstimulated cells or in the
absence of primary or secondary antibody, little enzymic activity
is detected. Increasing concentrations of PMA, however, yield
increased levels of enzymic product (Figure 1A), the dose–
response curve observed in the ELISA being in strict accordance
with the dose–response curve of PMA-enhanced MAPK activity,
as observed with Western blots or in itro kinase assays (Figures
1B and 1C). We found that a 1:250 dilution of anti-phospho-
p42}p44 MAPK combined low background with high sensitivity.
The specificity of PACE was established further by the ob-
servation that PD98059, which inhibits activation of MEK [12],
blocked the PMA-induced increase in absorbance (results not
shown). We concluded that PACE is a sensitive and specific
method for determining p42}p44 MAPK activation.
PACE is useful for primary isolated suspension cells
In the PACE described above, the immunoreactive substance,
i.e. phosphorylated p42}p44 MAPK, is immobilized via form-
aldehyde fixation of cells grown in 96-well tissue-culture plates.
To adapt the assay for cell types which do not naturally attach
to tissue-culture plastic, we adhered primary isolated human
granulocytes to poly-l-lysine-coated ELISA plates. When tested
in PACE according to the procedures employed for clone 4}4
macrophages we encountered a high background signal due to
endogenous peroxidase activity. Inclusion of 0.1% sodium azide
was sufficient to quench this activity. Concentration- and
temporal-dependent, PD98059-sensitive, fMLP-induced enzymic
product formation was readily detected (Figure 2). The p42}p44
MAPK activation by fMLP closely matched that observed in
primary isolated human granulocytes using classical kinase assays
or Western-blot analysis [11]. Thus PACE is a specific and
sensitive method for detection of p42}p44 MAPK phosphoryl-
Figure 3 Results of a p38 MAPK PACE
(A) Clone 4/4 cells were grown in a 96-well plate and stimulated with lipopolysaccharide (LPS),
followed by PACE procedures. Results obtained with different dilutions of a polyclonal anti-
phospho-p38 MAPK antibody are shown. Analysis of p38 MAPK by Western blotting (B) and
an in vitro kinase assay (C) are also shown. ATF, activating transcription factor.
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Figure 4 Results of a c-Akt/PKB PACE
Clone 4/4 cells grown in a 96-well plate were stimulated with insulin (Ins) followed by PACE procedures. (A) Results with different concentrations of an anti-phospho-c-Akt/PKB antibody are shown.
The effect of wortmannin (Wm) on insulin-stimulated cells was also determined (right-hand panel). Phosphorylation and activity of PKB determined by Western blotting (B) and in vitro kinase assay
(C) are also depicted. GSK, glycogen synthase kinase.
ation in both adherent and suspension cells. Furthermore, these
results show that this assay can also be useful for primary non-
transformed cells.
Development of a PACE for p38 MAPK, c-Akt/PKB and CREB
We investigated whether phosphospecific antibodies directed
against other signal-transduction components are applicable for
PACE. Macrophages were challenged with different concen-
trations of lipopolysaccharide, a potent activator of p38 MAPK.
Subsequently, the cells were fixed and incubated with different
concentrations of anti-phosphothreonine")!}phosphotyrosine")#
p38 MAPK antibody, followed by further routine ELISA
procedures. Again little enzymic product formation was detected
in the absence of either the primary or secondary antibody or in
the absence of lipopolysaccharide. Increasing concentrations of
lipopolysaccharide, however, produced a dose-dependent in-
crease in immunoreactivity (Figure 3A). We found that an anti-
phospho-p38 MAPK antibody dilution of 1:250 combined low
background with high sensitivity. The PACE-detected increase
in phosphorylated p38 MAPK corresponded to that observed
using Western blotting and to activity in in itro kinase assays
(Figure 3C). Although the phosphospecific p38 MAPK antibody
is reported to have cross-reactivity with other stress-activated
MAPKs, we only detected one band on the Western blot.
We also tested a phosphoserine%($-specific c-Akt}PKB anti-
body in PACE. Macrophages were stimulated with the PKB
activator insulin. As shown in Figure 4(A), we observed a dose-
dependent stimulation of enzymic product formation, in agree-
ment with the insulin-dependent increase of c-Akt}PKB activity
observed in both Western blotting (which also showed the
specificity of the antibody for c-Akt}PKB; Figure 4B) and in
itro kinase assays (Figure 4C). The optimal dilution of primary
antibody (1:100) was higher than those observed with the
p42}p44 MAPK and p38 MAPK PACE. The specificity, how-
ever, of the c-Akt}PKB PACE was confirmed by the sensitivity
of the insulin-induced signal to wortmannin. Finally we tested a
phosphoserine"$$-specific CREB antibody in PACE. To this end
clone 4}4 macrophages were stimulated with prostaglandin E
#
,
prostaglandin F
#
a and prostaglandin I
#
, since various prosta-
glandins have been reported to mediate CREB phosphorylation
[13–16], but the exact effects of these important inflammatory
mediators on CREB phosphorylation in macrophages have not
yet been assessed. As shown in Figure 5(A), prostaglandin E
#
resulted in CREB phosphorylation in macrophages as detected
by Western blotting (the antibody also cross-reacts with acti-
vating transcription factor 1, ATF1). After stimulation, a CREB
PACE was performed, whereas cAMP production was measured
in a parallel experiment. Prostaglandin F
#
a did not induce cAMP
production nor did it lead to the production of enzymic product
# 2000 Biochemical Society
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Figure 5 Effects of prostaglandin treatment on cAMP production and CREB
(A) Clone 4/4 cells were grown in 60-mm dishes and stimulated with prostaglandin E2 (PGE2). CREB phosphorylation was subsequently measured by Western blotting, using phosphospecific CREB
antibodies. (B) Effects of PGE2, PGI2 and PGF2a on cAMP production and CREB phosphorylation, measured using a commercial enzyme-linked immunoassay kit for cAMP (Amersham) and PACE.
ATF, activating transcription factor.
in a PACE assay (Figure 5B). In contrast, prostaglandin E
#
and
prostaglandin I
#
gave rise to a significant increase in cAMP
production and CREB immunoreactivity in PACE. Increases
in cAMP formation did not completely correlate with increases in
CREB phosphorylation at lower concentrations of prosta-
glandins, but this was attributed to cAMP-independent phos-
phorylation of CREB [14]. We concluded that PACE is a
convenient method to determine the phosphorylation state of
# 2000 Biochemical Society
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Figure 6 Correcting for differences in cell number by staining the wells
with crystal violet after the PACE procedure
Clone 4/4 cells were stimulated with PMA (TPA) and subjected to PACE (upper panel).
Subsequently cell numbers in individual wells were determined using crystal violet staining and
measuring absorbance at 595 nm, and the ratios were calculated (lower panel). A, Background
signal in the absence of primary antibody ; B, background in the absence of secondary antibody ;
C, background in the absence of both primary and secondary antibody. Note the reduction in
S.E.M. by correcting for differences in cell number.
important signal-transduction elements and is applicable for a
variety of different phosphospecific antibodies against both
protein kinases and transcription factors.
Correcting for differences in cell number
The validity of the PACE assay critically depends on two factors :
the loading of equal amounts of cells in different wells and the
quality of the primary antibody. We investigated, therefore,
whether it is possible to correct for the former factor using crystal
violet staining after the PACE procedure. As shown in Figure 6,
crystal violet staining works well under these conditions and
provides the opportunity to correct the signals measured in
PACE for cell number, as evident by the reduction in variability
in the assay. With respect to the latter factor, the antibodies
employed may react with other cellular proteins. This is not a
Received 11 April 2000/2 June 2000 ; accepted 26 June 2000
major problem if this antibody reactivity does not differ between
stimulated and unstimulated cells, as this will only result in some
additional background signal. If, however, immunoreactivity is
induced by stimulation of the cells, a problem may arise. Western
blotting of PMA-stimulated cells using the anti-phospho-p42}
p44 MAPK antibody reveals, after prolonged exposure, some
faint induced bands apart from the immunoreactivity at 42 and
44 kDa, and these bands may contribute to the signal measured
in the ELISA. Nevertheless, the enhanced chemiluminescence
used to detect antibody binding is not a very linear technique
(meaning that an increase in the amount of immunoreactive
material does not correspond closely with the increase in obtained
signal), is very sensitive and saturates quickly. The contribution
of phospho-p42}p44 MAPK to the signal measured in PACE
may therefore be even greater than estimated from the Western
blot. Indeed, one of the major advantages of PACE over
Western blotting is that the enzymic reaction underlying PACE
is of a more linear nature and therefore produces quantitatively
more accurate results.
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